Today, Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) based in South San Francisco, California, disclosed the awarding of grants as per the Rigel Pharmaceuticals, Inc. Inducement Plan. The plan was authorized by the Compensation Committee of Rigel's Board of Directors on April 7, 2026.